PDS Press Releases
The CEO Roundtable on Cancer (CEORT) Board of Directors today announced that William C. Louv, PhD, will lead the organization as Chief Executive Officer effective immediately, and it has elected two new Directors: David M. Reese, MD, Executive Vice President of R&D at Amgen, and Major General Elder Granger, MD, President and CEO of THE 5Ps, LLC.
Collaboration with HBCUs, HSIs, Merck, Amgen & SAS Elevates Cancer Prevention, Diagnosis, Quality Treatment Addressing Disparities in Health
A paper outlining consensus disease definitions for neurological toxicities in cancer patients undergoing immune checkpoint inhibitor treatment was published this week in the Journal for ImmunoTherapy of Cancer (JITC) by a team of physicians at 16 institutions. Neurologists and oncologists at Massachusetts General Hospital with support from scientists at Project Data Sphere® led the team to deliver the first consensus-based definitions of disease and severity criteria for any immune-related toxicity.
Project Data Sphere’s open access data platform has achieved a major milestone: Boosting the impact of oncology research by contributing to publication of more than 100 peer-reviewed articles that impact research and clinical practice.
After more than two decades of dedication to advance the prevention, diagnosis, and treatment of cancer, Dr. Martin J. Murphy has retired from the Board of Directors of the CEO Roundtable on Cancer and Project Data Sphere. The Board immediately elected him Director Emeritus.
The CEO Roundtable on Cancer has recognized the healthcare business of Merck KGaA, Darmstadt, Germany, operating as EMD Serono in the US and Canada, with the 2020 Dr. Charles A. Sanders Award for collaborative scientific research in cancer.
CARY, N.C. -- Use of the open-access cancer research platform established and hosted by Project Data Sphere® (PDS) is expanding and is influencing clinical practice through peer-reviewed publications based on the unique free digital “library-laboratory.”
